LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said it has received US approval for once-weekly type 2 diabetes treatment Tanzeum or albiglutide, with the company now anticipating the US launch of the treatment in the third-quarter of 2014. In a statement, the pharmaceutical giant sai Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives, including Chief Executive Andrew Witty, acquired shares and American Depositary Shares under the 2009 deferred annual bonus plan at a price of 1581.50 pence per share and USD53.42 per ADS each following a dividend Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Monday said Moncef Slaoui, a divisional chairman, and connected person K Slaoui, bought 5 American Depositary Shares under the GSK 401K plan at a price of USD51.76 per ADS. Glaxo shares were trading at USD51.89, up 0.2%, Monday. By Arvind B Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it was continuing to investigate allegations of bribery in its Polish operations and was co-operating fully with Poland's Central Anti-Corruption Office, after the BBC Panorama programme reported that eleven doctors and one of the comp Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it was continuing to investigate allegations of bribery in its Polish operations and was co-operating fully with Poland's Central Anti-Corruption Office, after the BBC Panorama programme reported that eleven doctors and one of the comp Read More
LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br />COMPANIES<br />----------<br /><strong>Aviva</strong> said it has agreed to sell its 47% stake in South Korean business Woori Aviva Life Insurance to NongHyup Financial Group, as the insurer co Read More
LONDON (Alliance News) - <strong>Aviva</strong> has Monday agreed to sell its 47% stake in its South Korean joint venture Woori Aviva Life Insurance to NongHyup Financial Group, as it continues to contract in the region and focus on markets where it can make the best returns on capital. <br /> Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning: ---------- FTSE 100 ---------- UBS REMOVED SCHRODERS FROM LEAST PREFERRED LIST ---------- UBS RAISES SCHRODERS PRICE TARGET TO 2700 (2650) PENCE - 'NEUTRAL' Read More
LONDON (Alliance News) - Glencore Xstrata said Monday it has agreed to sell its interest in the Las Bambas copper project in Peru to a Chinese consortium including MMG, Guoxin International Investment Corp and CITIC Metal Co for USD5.85 billion in cash. The deal is part of an agreement to w Read More
LONDON (Alliance News) - UK stocks are set to open firmly lower Monday, following another sharp sell-off on Wall Street on Friday and a weak Asian session overnight, and as increasing tensions in Ukraine are also likely to hurt investor sentiment. Wall Street continued its recent down trend Read More
LONDON (Alliance News) - UK-based drugmaker GlaxoSmithKline PLC is facing a criminal probe in Poland for allegedly paying bribes to doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday. According to the report, eleven doctors and one of Glaxo's regional managers have Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Friday said that the following executive directors and managers acquired shares at a price of 1585.037 pence per share on Thursday, via a dividend reinvestment.<br /><br /> <table class="u" cellspacing="0" cellpadding="0"><tbody><tr><td class="k" Read More
LONDON (Alliance News) - Glaxosmithkline PLC Thursday said senior executives, including Chief Executive Andrew Witty and Chief Financial Officer Simon Dingermans, acquired shares under the company share reward plan at a price of 1572.79 pence Wednesday.<br /><br />Details are as follows<br />< Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday backed flu treatment Relenza after a report from The Cochrane Collaboration suggested that it and Swiss healthcare company Roche Holdings AG's treatment Tamiflu have little effect. The implications of the report are significant as govern Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said a group of executives, including Chief Executive Andrew Witty, acquired shares as part of a dividend reinvestment of shares held within an ISA at a price of 1583.14 pence per share Friday.<br /><br />Details are as follows.<br /><br />< Read More
LONDON (Alliance News) - London's major stock indices closed firmly in the red Monday, led lower by technology stocks, following on from an equity sell-off on Wall Street on Friday.<br /><br />Meanwhile, concerns over a possible further encroachment into Ukraine by Russia also weighed heavily Read More